Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Respir Med ; 105(5): 651-8, 2011 May.
Article in English | MEDLINE | ID: mdl-21220195

ABSTRACT

Aging is associated with modifications of the immune system, defined as immunosenescence. This could contribute to a reduced prevalence of allergic disease in the elderly population. In this regard, atopy has rarely been considered in the clinical assessment of the geriatric respiratory patient. This article is a review of the available literature assessing the impact of age on atopy. In the majority of papers, we found a lower prevalence of atopy in the most advanced ages, both in healthy subjects and in individuals affected by allergic respiratory diseases. Unfortunately, no large, longitudinal studies performed in the general population have been conducted to further explore this observation. Although available data seem to favor the decline of allergen sensitization with age, the prevalence of allergic sensitizations in the elderly population with respiratory symptoms is substantial enough to warrant evaluation of the atopic condition. From a clinical perspective, allergic reactions in older adults can have the same or even worse manifestations compared to young people. For this reasons, the evaluation of the atopic condition also in the geriatric patient is recommended. Thus, the role of atopy as it pertains to the diagnosis, therapy (adoption of preventive measure such as removal of environmental allergen or immunotherapy), and prognosis (influence on morbidity and mortality) of chronic respiratory illnesses in the elderly is addressed.


Subject(s)
Aging/immunology , Allergens/immunology , Hypersensitivity/immunology , Immunoglobulin E/immunology , Skin Tests/methods , Age Factors , Aged , Aged, 80 and over , False Negative Reactions , Female , Humans , Hypersensitivity/diagnosis , Hypersensitivity/epidemiology , Male , Middle Aged , Prevalence
2.
Clin Physiol Funct Imaging ; 31(2): 101-7, 2011 Mar.
Article in English | MEDLINE | ID: mdl-20969726

ABSTRACT

BACKGROUND: The ratio of forced expiratory volume in 1 s and forced expiratory volume in 6 s (FEV1/FEV6) has been proposed as an alternative for FEV1/forced vital capacity (FVC) to diagnose obstructive diseases with less effort during spirometry; however, its prognostic value is unknown. We evaluated whether FEV1/FEV6 is a significant predictor of mortality in elderly subjects and compared its prognostic value with that of FEV1/FVC and FEV1. METHODS: One thousand nine hundred and seventy-one subjects, aged >65 years, participated in the population-based SA.R.A. study. During the baseline exam, a multidimensional assessment included spirometry. Vital status was determined during 6 years of follow-up. Association of all-cause, cardio-pulmonary (CP) and non-CP mortality with a low FEV1/FEV6, FEV1/FVC and FEV1 was evaluated. RESULTS: Among subjects with both survival data and acceptable spirometry including FEV6, all-cause unadjusted mortality rates were 7·00 and 2·46 per 100 person-years in subjects with FEV1/FEV6 less than and greater than or equal to lower limit of normal (LLN), respectively (mortality rate ratio: 2·84, 95%CI: 2·12-3·84). After adjustment for age, gender, FVC, smoke exposure and main comorbidities, the risk of all-cause mortality remained significantly increased in subjects with FEV1/FEV6

Subject(s)
Cardiovascular Diseases/physiopathology , Forced Expiratory Volume , Geriatric Assessment/methods , Lung Diseases/physiopathology , Lung/physiopathology , Spirometry , Age Factors , Aged , Aged, 80 and over , Cardiovascular Diseases/mortality , Cause of Death , Chi-Square Distribution , Female , Humans , Italy , Kaplan-Meier Estimate , Lung Diseases/mortality , Male , Predictive Value of Tests , Prognosis , Proportional Hazards Models , Risk Assessment , Risk Factors , Survival Rate , Time Factors , Vital Capacity
3.
Expert Rev Respir Med ; 4(5): 585-91, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20923338

ABSTRACT

Aging is associated with modifications of the immune system and this could contribute to a reduced prevalence of allergic disease in the elderly. Atopy has rarely been considered in the clinical assessment of the geriatric respiratory patient. This article is a review of the available literature assessing the impact of age on atopy in the asthmatic patient. In the majority of papers, we found a lower prevalence of atopy in the most advanced ages, both in healthy subjects and in individuals affected by allergic respiratory diseases. No large, longitudinal studies performed in the general population have been conducted to confirm this observation. Although available data seem to favor the decline of allergen sensitization with age, the prevalence of allergic sensitizations in the elderly population with respiratory symptoms is substantial enough to warrant evaluation of the atopic condition. For this reason, the evaluation of the atopic condition in the geriatric patient is recommended. The role of atopy as regards diagnosis, therapy and prognosis of asthma in the elderly is addressed.


Subject(s)
Aging , Asthma/diagnosis , Hypersensitivity/diagnosis , Age Factors , Aged , Aged, 80 and over , Aging/immunology , Allergens/immunology , Asthma/epidemiology , Asthma/immunology , Asthma/therapy , Humans , Hypersensitivity/epidemiology , Hypersensitivity/immunology , Hypersensitivity/therapy , Prevalence , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL
...